Victory Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.85M	Buy	351,630 +79,058	+29%	+$2.59M	0.01%	1086
2025 Q4	$10.2M	Buy	272,572 +36,904	+16%	+$1.21M	0.01%	1055
2025 Q3	$6.5M	Buy	235,668 +60,881	+35%	+$2.1M	﹤0.01%	1242
2025 Q2	$5.52M	Sell	174,787 -37,107	-18%	-$1.19M	﹤0.01%	1283
2025 Q1	$7.03M	Buy	211,894 +65,285	+45%	+$2.34M	0.01%	1179
2024 Q4	$5.04M	Buy	146,609 +77,611	+112%	+$2.67M	0.01%	1262
2024 Q3	$2.76M	Sell	68,998 -15,966	-19%	-$561K	﹤0.01%	1400
2024 Q2	$2.56M	Buy	84,964 +29,816	+54%	+$897K	﹤0.01%	1369
2024 Q1	$1.85M	Buy	55,148 +37,368	+210%	+$1.2M	﹤0.01%	1476
2023 Q4	$574K	Sell	17,780 -14,809	-45%	-$413K	﹤0.01%	1959
2023 Q3	$1.07M	Buy	32,589 +3,605	+12%	+$125K	﹤0.01%	1622
2023 Q2	$1.02M	Sell	28,984 -14,579	-33%	-$503K	﹤0.01%	1664
2023 Q1	$1.42M	Buy	43,563 +3,317	+8%	+$151K	﹤0.01%	1521
2022 Q4	$2.22M	Buy	40,246 +18,592	+86%	+$1.02M	﹤0.01%	1398
2022 Q3	$959K	Sell	21,654 -139	-0.6%	-$6.78K	﹤0.01%	1755
2022 Q2	$1.06M	Sell	21,793 -3,302	-13%	-$149K	﹤0.01%	1711
2022 Q1	$1.13M	Buy	25,095 +14,877	+146%	+$607K	﹤0.01%	1741
2021 Q4	$436K	Buy	+10,218	New	+$407K	﹤0.01%	2220